Navigation Links
Low doses of arsenic cause cancer in male mice
Date:7/8/2014

Mice exposed to low doses of arsenic in drinking water, similar to what some people might consume, developed lung cancer, researchers at the National Institutes of Health have found.

Arsenic levels in public drinking water cannot exceed 10 parts per billion (ppb), which is the standard set by the U.S. Environmental Protection Agency. However, there are no established standards for private wells, from which millions of people get their drinking water.

In this study, the concentrations given to the mice in their drinking water were 50 parts per billion (ppb), 500 ppb, and 5,000 ppb. 50 ppb is the lowest concentration that has been tested in an animal study, and researchers say that because of differing rates of metabolism, mice need to be exposed to greater concentrations of arsenic in drinking water than humans to achieve the same biological dose and similar health effects.

The researchers used a model that duplicates how humans are exposed to arsenic throughout their entire lifetime. In the study, the mice were given arsenic three weeks before breeding and throughout pregnancy and lactation. Arsenic was then given to the offspring after weaning, and all through adulthood at concentrations relevant to human exposure. The researchers looked at the tumors in the adult offspring.

"This is the first study to show tumor development in animals exposed to very low levels of arsenic, levels similar to which humans might be exposed," said Michael Waalkes, Ph.D., lead author on the paper and director of the National Toxicology Program (NTP) Laboratory. "The results are unexpected and certainly give cause for concern."

Arsenic is present in the environment as a naturally occurring substance or due to contamination from human activity. Arsenic may be found in many foods, including grains, fruits, and vegetables, where it is present due to absorption from the soil and water. This study focused on inorganic arsenic, which often occurs in excess in the drinking water of millions of people worldwide, and has been previously shown to be a human carcinogen.

In the study, more than half of the male offspring mice developed significant increases in benign and malignant lung tumors at the two lower doses (50 ppb and 500 ppb). Female offspring also developed benign tumors at the lower concentrations. Interestingly, the researchers did not find significant increases in lung tumors in either sex at the highest dose (5,000 ppb).

"Although this is only one study, it adds to a growing body of evidence showing adverse health effects from very low exposures to arsenic, raising the possibility that no level of arsenic appears to be safe," said Linda Birnbaum, Ph.D, director of the National Institute of Environmental Health Sciences (NIEHS) and NTP.


'/>"/>

Contact: Robin Mackar
rmackar@niehs.nih.gov
919-541-0073
NIH/National Institute of Environmental Health Sciences
Source:Eurekalert  

Related medicine news :

1. Safety and immunogenicity of 2 doses of the HPV-16/18 AS04 adjuvanted vaccine Cervarix
2. Study identifies risk factors for non-fatal overdoses
3. Bisphenol A is affecting us at much lower doses than previously thought
4. New discovery could dramatically reduce leishmaniasis treatment doses and side effects
5. Tailored doses of cytostatic improve survival rate
6. More Woman Dying From Prescription Drug Overdoses Than Cancer
7. Prescription Drug Overdoses Increase 400% For Women
8. Exposure to low doses of BPA linked to increased risk of prostate cancer in human stem cells
9. Blacks With Certain Gene Need Lower Doses of Warfarin: Study
10. High Doses of Common Painkillers May Raise Risk for Heart Trouble
11. Icahn School of Medicine at Mount Sinai and Bene Pharmachem Gmbh to Collaborate on Clinical Studies for Mucopolysaccaridoses
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Low doses of arsenic cause cancer in male mice
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the ... the most widely used electronic patient signatures solution in healthcare . ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended ... all facets of clinical trial planning and management. Pharmica discussed the importance of ... In addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
(Date:2/17/2017)... ... 17, 2017 , ... Like most hospitals across the nation, Onslow Memorial Hospital ... the Hospital Readmission Reduction Program (HRRP), the return of a patient to the hospital ... the nation. While many providers are struggling to leverage limited resources and technology, Onslow ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, ... expected to grow at a CAGR of 9.4% from 2017-2022 and ... at a CAGR of 9.5% from 2017 to 2027. The market ... ... benefit you Read on to discover how you can exploit ...
(Date:2/17/2017)... 2017 Arvinas LLC, a private biotechnology company ... degradation, today announced the presentation of new preclinical data ... poster session at the American Society of Clinical Oncology ... Orlando, FL. "The new ... the potential of PROTACs to drive durable and robust ...
(Date:2/17/2017)... and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing ... ... the US, Canada , Japan , ... of World. Annual estimates and forecasts are provided for the period 2015 ... Market data and analytics are derived from primary and secondary research. ...
Breaking Medicine Technology: